Searched for: person:hainea01
in-biosketch:true
Evaluating the impact of specialty pharmacies on access to biologics in patients with moderate-to-severe asthma
Scharfenberger, Thomas; Wang, Xiaojia; Berglas, Rachel; Kazi, Ananna; Mahajan, Lakshmi; Granados, Nitza; Haines, Adam; Fiori, Kevin; Jariwala, Sunit P
OBJECTIVE/UNASSIGNED:To evaluate whether specialty pharmacy use reduces delays from biologic prescription to insurance approval and administration in patients with moderate-to-severe asthma. METHODS/UNASSIGNED:We conducted a retrospective cohort study of patients prescribed asthma biologics in the Bronx, New York. Cohorts were defined by time period: before specialty pharmacy implementation (2017-2020) and after (2020-2023). Primary outcomes were time from prescription to insurance approval and administration. Wilcoxon rank-sum tests compared groups, and multivariable regression models adjusted for covariates. RESULTS/UNASSIGNED: = .057). CONCLUSIONS/UNASSIGNED:Specialty pharmacy implementation significantly accelerated approval and showed a trend toward faster treatment initiation. Delays in administration persisted despite adjustment for patient-level factors, underscoring the role of other barriers. Larger, multi-center studies are warranted.
PMID: 41704088
ISSN: 1532-4303
CID: 6072783
Challenges with nasal challenges: Diagnosing local allergic rhinitis in the Bronx population
Haines, Adam; Rosenstreich, David; Hudes, Golda; Ramesh, Manish; Fang, Christina H; Colley, Patrick; Akbar, Nadeem; Ferastraoaru, Denisa
PMID: 41974226
ISSN: 1534-4436
CID: 6072784
Advocating for the vulnerable: addressing anaphylaxis in infancy through awareness, research, and policy
Fox, Eryn; Haines, Adam; Ponda, Punita; ,
Infant anaphylaxis, a life-threatening condition, remains poorly understood due to limited research in this vulnerable population. Financial, ethical, and regulatory barriers hinder pediatric research, leaving critical gaps in knowledge. Physician advocacy is vital in addressing these challenges by urging policymakers to prioritize increased funding for pediatric studies at national and international levels. Enhanced investment would support improved diagnosis and management of poorly understood conditions early in life, offering better outcomes for infants and their families. By advancing research in this area, we can address significant unmet needs and foster healthier futures for our youngest patients.
PMID: 39962157
ISSN: 1530-0447
CID: 6072782
Examining factors associated with poor metered-dose inhaler technique in a cohort of bronx patients with uncontrolled asthma
Haines, Adam; Scharfenberger, Thomas; Rashtian, Justin; Godavarthi Raju, Lakhi; Jariwala, Sunit
OBJECTIVE/UNASSIGNED:Most studies investigating at-risk groups for poor inhaler technique (PT) have been in adolescents. However, evidence suggests older age correlates with PT. This study aimed to correlate patient characteristics with PT in an adult asthma cohort in the Bronx. METHODS/UNASSIGNED: = 58) at their initial visit. Independent variables included age, sex, ethnicity, language, insurance status, BMI, depression severity, and socioeconomic data. Two logistic regression models were created to assess odds of PT among independent variables at initial visit and odds of improvement in technique at follow-up. RESULTS/UNASSIGNED: = 0.031). CONCLUSIONS/UNASSIGNED:At baseline, individuals with PT were younger and more likely to be on a public health insurance plan. Increasing age, increasing BMI, and female sex were associated with higher odds of PT at the baseline visit, but were not associated with improvements in technique.
PMID: 39225405
ISSN: 1532-4303
CID: 6072780
Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma
Desai, Mauli; Haines, Adam; Oppenheimer, John J
Presently, there are 6 biologic agents available for treatment of asthma. Each of these agents has undergone robust clinical trials in their approval programs. Such studies rely upon very rigid entry criteria that may not translate to real-world efficacy. Thus, exploring the efficacy of these agents in a larger, more heterogeneous, population brings a sense of comfort regarding their efficacy in the real-world. This review explores the available literature regarding the use of biologics in the real world, with a focus on markers of likely response to therapy.
PMID: 39389721
ISSN: 1557-8607
CID: 6072781
Primary Pancreatic Lymphoma in the Tail: A Rare Anatomic Presentation [Case Report]
Kothari, Pooja; Haines, Adam; Bhardwaj, Meera P; Patel, Viraj V; Ho, Sammy
Non-Hodgkin's lymphoma is a common type of cancer, whose most common site of extranodal involvement is the gastrointestinal tract. However, primary presentation in the pancreas remains uncommon. Among cases with pancreatic involvement, the disease is often found in the head and rarely in the tail. Here, we present a case of a 56-year-old male patient with acute epigastric pain, early satiety, and abdominal distention. CT imaging showed a mass of the pancreatic tail with surrounding lymphadenopathy, concerning lymphoma. Endoscopic ultrasound-guided fine needle aspiration (EUS-guided FNA) diagnosed mature B-cell lymphoma, meeting novel diagnostic criteria for the rare diagnosis of primary pancreatic lymphoma (PPL).
PMCID:9767814
PMID: 36569730
ISSN: 2168-8184
CID: 6072779
Transcutaneous Electrical Nerve Stimulation as a Treatment for Neuropathic Cough: A Tolerability and Feasibility Study
Michalowski, Alexandra; Haines, Adam; Shaparin, Naum; Gritsenko, Karina; Kaye, Alan D; Cornett, Elyse M; Lerner, Michael Z
Transcutaneous electrical nerve stimulation (TENS) is a form of electroanalgesia used for neuropathic pain disorders. Refractory chronic cough, or "neuropathic cough," may be physiologically similar to other neuropathic pain conditions. This study explored the tolerability and feasibility of using TENS as a treatment for neuropathic cough. Laryngeal TENS was administered to five subjects with neuropathic cough. One electrode was placed over the lateral thyrohyoid membrane, and a second over the cricothyroid space. A frequency of 120 Hz was applied for 30 min. Participants rated symptoms pre-, during, and post-TENS treatment using a Likert scale. Laryngeal TENS was well tolerated by all subjects. Adverse effects included brief neck discomfort when increasing TENS intensity and an event of mild post-treatment hoarseness. The self-reported scores trended toward a reduction in symptom severity during and after treatment. Controlled trials using this method would elucidate the use of TENS for treatment of patients suffering from chronic cough.
PMCID:8571432
PMID: 34002358
ISSN: 2193-8253
CID: 6072777
The association of hypnotics with incident cardiovascular disease and mortality in older women with sleep disturbances
Haines, Adam; Shadyab, Aladdin H; Saquib, Nazmus; Kamensky, Victor; Stone, Katie; Wassertheil-Smoller, Sylvia
BACKGROUND/OBJECTIVE:Insomnia is common in older women and is associated with higher cardiovascular disease (CVD) risk. Nonbenzodiazepine GABA agonists (Z-drugs) are the most commonly prescribed sleep aids. The study objective was to determine whether the use of Z-drugs is associated with the risk of developing CVD and mortality in older women with sleep disturbances. PATIENTS/METHODS:The study cohort included post-menopausal women who, at baseline, scored ≥9 with the Women's Health Initiative Insomnia Rating Scale (N = 40,728). Members of the cohort were categorized as users of Z-drugs, users of other prescription hypnotics, or non-users. Outcomes were composite CVD (congestive heart failure, stroke, and fatal/non-fatal myocardial infarction) and mortality. Hazard ratios were estimated from Cox proportional hazards regression models adjusted for demographics, medical history, and sleep measures. To address potential confounding by indication, we also adjusted for propensity to be prescribed hypnotics. RESULTS:The mean age of our cohort was 63.57 years (SD = 7.23) and mean follow-up time after the initial follow-up visit was 14.0 years (SD = 6.3). Z-drug use was significantly associated with an increased risk of composite CVD (HR = 1.35, 95%CI: 1.02-1.79) and all-cause mortality (HR = 1.38, 95%CI: 1.13-1.69). When groups were divided by heavy and casual use, only heavy users (≥3 times per week) had an increased risk of mortality. CONCLUSIONS:Z-drugs use was associated with an increased risk for death and CVD in post-menopausal women being treated for sleep disturbances. Additional research is needed to evaluate both frequency and duration of Z-drug use.
PMID: 34087626
ISSN: 1878-5506
CID: 6072778
Examining Referral Patterns between Otolaryngology and Gastroenterology: A Window into Potential Inter-Specialty Knowledge Gaps
Haines, Adam; Kohli, Nikita; Lerner, Benjamin A; Lerner, Michael Z
OBJECTIVE:The objective of this study was to examine referral patterns between otolaryngology and gastroenterology in order to delineate areas of clinical overlap, as well as to identify areas that might benefit from improved inter-specialty communication and collaboration. METHODS:. The ICD-10 codes in both cohorts were reviewed and 13 distinct "reason for referral" categories were defined. The rates of referral for each category were then calculated for each of the referral cohorts. RESULTS:Otolaryngology referred to gastroenterology at a greater rate than gastroenterology referred to otolaryngology, despite seeing fewer total patients than gastroenterology. For referrals from gastroenterology to otolaryngology, the three most frequent referral reasons were oral cavity/oropharyngeal pathology (28.3%), dysphagia (28.3%), and gastroesophageal reflux disease/laryngopharyngeal reflux disease (GERD/LPRD) (11.3%). For referrals from otolaryngology to gastroenterology, the three most frequent referral reasons were GERD/LPRD (61.7%), dysphagia (18.6%), and esophageal pathology (5.3%). CONCLUSIONS:GERD/LPRD was more frequently referred out by otolaryngology than it was by gastroenterology, suggesting the need for further characterization of the discrepancy in management of a disease commonly treated by both specialties. The discrepant rates of referral for dysphagia also suggest a need to better understand what factors contribute to the differences in management of another clinical condition commonly assessed by both specialties. LEVEL OF EVIDENCE/METHODS:4.
PMID: 32249595
ISSN: 1943-572x
CID: 6072776